Escherichia coli O157:H7

被引:491
作者
Mead, PS [1 ]
Griffin, PM [1 ]
机构
[1] Ctr Dis Control & Prevent, Foodborne & Diarrheal Dis Branch, Atlanta, GA 30333 USA
关键词
D O I
10.1016/S0140-6736(98)01267-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Escherichia coli O157 was first identified as a human pathogen in 1982. One of several Shiga toxin-producing serotypes known to cause human illness, the organism probably evolved through horizontal acquisition of genes for Shiga toxins and other virulence factors. E coli O157 is found regularly in the faeces of healthy cattle, and is transmitted to humans through contaminated food, water, and direct contact with infected people or animals. Human infection is associated with a wide range of clinical illness, including asymptomatic shedding, non-bloody diarrhoea, haemorrhagic colitis, haemolytic uraemic syndrome, and death. Since laboratory practices vary, physicians need to know whether laboratories in their area routinely test for E coli O157 in stool specimens. Treatment with antimicrobial agents remains controversial: some studies suggest that treatment may precipitate haemolytic uraemic syndrome, and other studies suggest no effect or even a protective effect. Physicians can help to prevent E coli O157 infections by counselling patients about the hazards of consuming undercooked ground meat or unpasteurised milk products and juices, and about the importance of handwashing to prevent the spread of diarrhoeal illness, and by informing public health authorities when they see unusual numbers of cases of bloody diarrhoea or haemolytic uraemic syndrome.
引用
收藏
页码:1207 / 1212
页数:6
相关论文
共 88 条
[1]  
*ADV COMM MICR SAF, 1995, ESCH COL
[2]  
Ahmed A., 1998, ESCHERICHIA COLI O15, P59
[3]  
AKASHI S, 1994, EUR J PEDIATR, V153, P650, DOI 10.1007/BF02190685
[4]   A PHASE-I STUDY OF CHEMICALLY SYNTHESIZED VEROTOXIN (SHIGA-LIKE TOXIN) PK-TRISACCHARIDE RECEPTORS ATTACHED TO CHROMOSORB FOR PREVENTING HEMOLYTIC-UREMIC SYNDROME [J].
ARMSTRONG, GD ;
ROWE, PC ;
GOODYER, P ;
ORRBINE, E ;
KLASSEN, TP ;
WELLS, G ;
MACKENZIE, A ;
LIOR, H ;
BLANCHARD, C ;
AUCLAIR, F ;
THOMPSON, B ;
RAFTER, DJ ;
MCLAINE, PN .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) :1042-1045
[5]   ENZYME-LINKED IMMUNOSORBENT ASSAYS FOR DETECTING ANTIBODIES TO SHIGA-LIKE TOXIN-I, SHIGA-LIKE TOXIN-II, AND ESCHERICHIA-COLI O157-H7 LIPOPOLYSACCHARIDE IN HUMAN SERUM [J].
BARRETT, TJ ;
GREEN, JH ;
GRIFFIN, PM ;
PAVIA, AT ;
OSTROFF, SM ;
WACHSMUTH, IK .
CURRENT MICROBIOLOGY, 1991, 23 (04) :189-195
[6]   LABORATORY INVESTIGATION OF A MULTISTATE FOOD-BORNE OUTBREAK OF ESCHERICHIA-COLI O157-H7 BY USING PULSED-FIELD GEL-ELECTROPHORESIS AND PHAGE TYPING [J].
BARRETT, TJ ;
LIOR, H ;
GREEN, JH ;
KHAKHRIA, R ;
WELLS, JG ;
BELL, BP ;
GREENE, KD ;
LEWIS, J ;
GRIFFIN, PM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (12) :3013-3017
[7]   Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections [J].
Bell, BP ;
Griffin, PM ;
Lozano, P ;
Christie, DL ;
Kobayashi, JM ;
Tarr, PI .
PEDIATRICS, 1997, 100 (01) :art. no.-e12
[8]   A MULTISTATE OUTBREAK OF ESCHERICHIA-COLI-O157-H7 ASSOCIATED BLOODY DIARRHEA AND HEMOLYTIC-UREMIC-SYNDROME FROM HAMBURGERS - THE WASHINGTON EXPERIENCE [J].
BELL, BP ;
GOLDOFT, M ;
GRIFFIN, PM ;
DAVIS, MA ;
GORDON, DC ;
TARR, PI ;
BARTLESON, CA ;
LEWIS, JH ;
BARRETT, TJ ;
WELLS, JG ;
BARON, R ;
KOBAYASHI, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (17) :1349-1353
[9]   TRANSMISSION OF ESCHERICHIA-COLI O157-H7 INFECTION IN MINNESOTA CHILD DAY-CARE FACILITIES [J].
BELONGIA, EA ;
OSTERHOLM, MT ;
SOLER, JT ;
AMMEND, DA ;
BRAUN, JE ;
MACDONALD, KL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (07) :883-888
[10]   Surveillance for Escherichia coli O157:H7 infections in Minnesota by molecular subtyping [J].
Bender, JB ;
Hedberg, CW ;
Besser, JM ;
Boxrud, DJ ;
MacDonald, KL ;
Osterholm, MT .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) :388-394